Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Robert Ritch, MD is a specialized ophthalmology practice and clinical research entity based in New York City, operating as Robert Ritch, MD, LLC and Glaucoma Associates of New York (GANY). Founded by Dr. Robert Ritch, a pioneer in glaucoma research and treatment, the organization focuses on the diagnosis, management, and surgical treatment of various forms of glaucoma, including exfoliation syndrome and pigment dispersion syndrome. The practice is closely integrated with the New York Eye and Ear Infirmary of Mount Sinai and is involved in numerous clinical trials and academic collaborations. Dr. Ritch has developed innovative laser surgical techniques and founded several non-profit organizations, such as The Glaucoma Foundation and the New York Glaucoma Research Institute, to advance the field of ophthalmology. The entity provides comprehensive clinical care while simultaneously driving research into the genetic and systemic factors contributing to optic nerve damage. It also offers international educational programs, having trained over 150 clinical and research fellows from more than 50 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Robert Ritch, MD.